scPharmaceuticals Inc. (SCPH) Misses Q3 EPS by 4c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.4 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Samsung 2q Oper Profit 89.40t Won, Est. 84.2t Won
• UBS Reiterates Neutral Rating on Carter's (CRI)